Genvoya 150 MG / 150 MG / 200 MG / 10 MG Oral Tablet
- RxCUI
- 1721619
- RxNorm name
- Genvoya 150 MG / 150 MG / 200 MG / 10 MG Oral Tablet
- Display name
- Genvoya 150 MG / 150 MG / 200 MG / 10 MG Oral Tablet
- Full name
- Genvoya 150 MG / 150 MG / 200 MG / 10 MG Oral Tablet
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:53
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Genvoya | ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE | Gilead Sciences, Inc. | 34784acf-15ed-4715-b504-eb30430518e9 | 2025-02-03 | Boxed warning, Warnings, Adverse reactions | 1721619 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 34784acf-15ed-4715-b504-eb30430518e9 | Genvoya 150 MG / 150 MG / 200 MG / 10 MG Oral Tablet [PSN] · cobicistat 150 MG / elvitegravir 150 MG / emtricitabine 200 MG / tenofovir alafenamide 10 MG Oral Tablet [Genvoya] [SBD] · Genvoya (cobicistat 150 MG / elvitegravir 150 MG / emtricitabine 200 MG / tenofovir alafenamide 10 MG (as tenofovir alafenamide fumarate 11.2 MG)) Oral Tablet [SY] | 3 | 22 | These highlights do not include all the information needed to use GENVOYA safely and effectively. See full prescribing information for GENVOYA. GENVOYA ® (elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2015 | 20250203 |